U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07377994) titled 'To Evaluate the Effect of Bacillus Coagulans Based Product in Gut Health and Immunomodulatory Effect in Healthy Adults' on Jan. 05.
Brief Summary: This randomized, double-blind, placebo-controlled clinical trial is designed to evaluate the effects of a Bacillus coagulans-based probiotic product on gut health, immunological parameters, and overall tolerability in healthy adult participants. The study aims to generate clinical evidence on the role of Bacillus coagulans in maintaining intestinal homeostasis and modulating immune responses under normal physiological conditions.
Gut health will be assessed through both objective and sub...